Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.
作者信息
Kiang Tony K L, Ford Jo-Ann, Yoshida Eric M, Partovi Nilufar
机构信息
, BSc(Pharm), PhD, ACPR, is a Clinical Pharmacist at Providence Health Care and a postdoctoral fellow (part-time) in the Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia.
出版信息
Can J Hosp Pharm. 2011 Jul;64(4):262-70. doi: 10.4212/cjhp.v64i4.1039.
Abstract
摘要
相似文献
1
Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.
Can J Hosp Pharm. 2011 Jul;64(4):262-70. doi: 10.4212/cjhp.v64i4.1039.
2
Combined nitrofurantoin toxicity to liver and lung.
Gastroenterology. 1992 Apr;102(4 Pt 1):1396-9.
3
Nitrofurantoin toxicity to both liver and lungs.
Liver. 1997 Jun;17(3):166-7. doi: 10.1111/j.1600-0676.1997.tb00800.x.
4
Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment.
Ann Pharmacother. 2004 Apr;38(4):612-6. doi: 10.1345/aph.1D306. Epub 2004 Feb 13.
5
Nitrofurantoin-induced lung- and hepatotoxicity.
Ann Hepatol. 2007 Apr-Jun;6(2):119-21.
6
Hepatitis due to nitrofurantoin.
Med J Aust. 1992 Mar 2;156(5):347-9. doi: 10.5694/j.1326-5377.1992.tb139795.x.
7
Nitrofurantoin-induced immune-mediated lung and liver disease.
Vojnosanit Pregl. 2012 Jun;69(6):536-40.
8
Comparative studies of sheep lung and liver nitrofurantoin reductase.
Comp Biochem Physiol C Comp Pharmacol Toxicol. 1993 Oct;106(2):579-84. doi: 10.1016/0742-8413(93)90182-k.
9
Endstage liver disease associated with nitrofurantoin requiring liver transplantation.
Ann Pharmacother. 1993 Oct;27(10):1193-4. doi: 10.1177/106002809302701007.
10
[Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998].
Ugeskr Laeger. 1999 Nov 29;161(48):6650-2.
引用本文的文献
1
Development of a Physiologically Based Pharmacokinetic Model for Nitrofurantoin in Rabbits, Rats, and Humans.
Pharmaceutics. 2023 Aug 25;15(9):2199. doi: 10.3390/pharmaceutics15092199.
2
Concomitant Nitrofurantoin-Induced Autoimmune Hepatitis and Interstitial Lung Disease.
GE Port J Gastroenterol. 2021 Jun 30;29(4):273-279. doi: 10.1159/000516940. eCollection 2022 Jul.
本文引用的文献
1
Ciprofloxacin-induced acute cholestatic hepatitis.
Ann Hepatol. 2009 Oct-Dec;8(4):400-1.
2
Nitrofurantoin-induced acute liver damage in pregnancy.
Arh Hig Rada Toksikol. 2009 Sep;60(3):357-61. doi: 10.2478/10004-1254-60-2009-1940.
3
Acute kidney injury, hepatitis, and CPK elevation associated with nitrofurantoin therapy.
Am J Med Sci. 2009 Feb;337(2):132-3. doi: 10.1097/MAJ.0b013e31816c43a4.
4
Concomitant pulmonary and hepatic toxicity secondary to nitrofurantoin: a case report.
J Med Case Rep. 2007 Aug 1;1:59. doi: 10.1186/1752-1947-1-59.
5
Nitrofurantoin-induced lung- and hepatotoxicity.
Ann Hepatol. 2007 Apr-Jun;6(2):119-21.
6
Pulmonary and hepatic toxicity due to nitrofurantoin and fluconazole treatment.
Ann Pharmacother. 2004 Apr;38(4):612-6. doi: 10.1345/aph.1D306. Epub 2004 Feb 13.
7
Nitrofurantoin: a study in vitro and in vivo in one hundred cases of urinary infection.
J Am Med Assoc. 1954 Aug 21;155(17):1470-3. doi: 10.1001/jama.1954.03690350012004.
8
Nitrofurantoin-induced chronic active hepatitis.
Isr Med Assoc J. 2002 Mar;4(3):184-6.
9
An update on the role of nitrofurans in the management of urinary tract infections.
Drugs. 2001;61(3):353-64. doi: 10.2165/00003495-200161030-00004.
10
Protection against nitrofurantoin-induced oxidative stress by coelenterazine analogues and their oxidation products in rat hepatocytes.
Free Radic Res. 2001 Mar;34(3):285-96. doi: 10.1080/10715760100300251.
Zotero 插件